N/A
Completed N=220
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
Lung Cancer · Biomarkers · Fatty Acids
Source: ClinicalTrials.gov NCT01692951 ↗
Enrolled (actual)
220
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcomePrimary: Compare Concentration of Fatty Acids and Their Metabolites — 5.70; 2.95; 4.24; 3.18 mg/mL
Summary
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Compare Concentration of Fatty Acids and Their Metabolites |
5.70; 2.95; 4.24; 3.18; 0.59; 0.34 | — |
Eligibility Criteria
Inclusion Criteria
- Age from 40 to 80
- Lung adenocarcinoma with pathological diagnosis
- Lung squamous cell carcinoma with pathological diagnosis
- Control patients should have at least one of the following criteria: (1) current or ex-smoker with at least a 10 pack-year history, (2) a first-degree relative with a history of lung cancer, or (3) a clinical diagnosis of COPD.
Exclusion Criteria
- Lung cancer patient without serum sample before the initiation of treatment
Data sourced from ClinicalTrials.gov (NCT01692951). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.